ENTRY       D11029                      Drug
NAME        Andexanet alfa (USAN/INN);
            Andexanet alfa (genetical recombination) (JAN);
            Andexxa (TN);
            Ondexxya (TN)
PRODUCT     ANDEXXA (Alexion Pharmaceuticals)
            ANDEXXA (AstraZeneca Pharmaceuticals LP)
SEQUENCE    (heavy chain)
            IVGGQECKDG ECPWQALLIN EENEGFCGGT ILSEFYILTA AHCLYQAKRF KVRVGDRNTE
            QEEGGEAVHE VEVVIKHNRF TKETYDFDIA VLRLKTPITF RMNVAPACLP ERDWAESTLM
            TQKTGIVSGF GRTHEKGRQS TRLKMLEVPY VDRNSCKLSS SFIITQNMFC AGYDTKQEDA
            CQGDAGGPHV TRFKDTYFVT GIVSWGEGCA RKGKYGIYTK VTAFLKWIDR SMKTRGLPKA
            KSHAPEVITS SPLK
            (light chan)
            ANSFLFWNKY KDGDQCETSP CQNQGKCKDG LGEYTCTCLE GFEGKNCELF TRKLCSLDNG
            DCDQFCHEEQ NSVVCSCARG YTLADNGKAC IPTGPYPCGK QTLER
            (Disulfide bridge: H7-H12, H27-H43, H108-L98, H156-H170, H181-H209, L16-L27, L21-L36, L38-L47, L55-L66, L62-L75, L77-L90)
  TYPE      Peptide
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01662  Factor Xa inhibitor
REMARK      Therapeutic category: 3399
            ATC code: V03AB38
            Product: D11029<JP/US>
EFFICACY    Anticoagulant reversal (factor Xa inhibitors)
COMMENT     Ligand decoy
            Reversal of anticoagulation caused by factor Xa inhibitors
TARGET      F10 [HSA:2159] [KO:K01314]
  PATHWAY   hsa04610(2159)  Complement and coagulation cascades
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AB Antidotes
                 V03AB38 Andexanet alfa
                  D11029  Andexanet alfa (USAN/INN) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               339  Miscellaneous
                3399  Others
                 D11029  Andexanet alfa (USAN/INN); Andexanet alfa (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01662  Factor Xa inhibitor
                D11029  Andexanet alfa
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Serine peptidases
                F10
                 D11029  Andexanet alfa (USAN/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11029
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11029
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11029
DBLINKS     CAS: 1262449-58-0
            PubChem: 350078348
///
